BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25547608)

  • 1. Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome.
    Simonetta F; Guerne PA; Tirefort Y; Masouridi-Levrat S; Roosnek E; Chalandon Y
    Joint Bone Spine; 2015 May; 82(3):216-7. PubMed ID: 25547608
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].
    Zhang Z; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome.
    Chung YJ; Fry TJ; Aplan PD
    PLoS One; 2017; 12(9):e0185219. PubMed ID: 28953912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which lower risk myelodysplastic syndromes should be treated with allogeneic hematopoietic stem cell transplantation?
    Robin M; Fenaux P
    Leukemia; 2020 Oct; 34(10):2552-2560. PubMed ID: 32661295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of allogeneic stem cell transplantation for myelodysplastic syndromes and aplastic anemia.
    Cutler C
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):77-81. PubMed ID: 25696838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
    Trobaugh-Lotrario AD; Kletzel M; Quinones RR; McGavran L; Proytcheva MA; Hunger SP; Malcolm J; Schissel D; Hild E; Giller RH
    Bone Marrow Transplant; 2005 Jan; 35(2):143-9. PubMed ID: 15558042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and Medicaid Services.
    Giralt SA; Horowitz M; Weisdorf D; Cutler C
    J Clin Oncol; 2011 Feb; 29(5):566-72. PubMed ID: 21220586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Lee HC; Saliba RM; Rondon G; Chen J; Charafeddine Y; Medeiros LJ; Alatrash G; Andersson BS; Popat U; Kebriaei P; Ciurea S; Oran B; Shpall E; Champlin R
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1948-54. PubMed ID: 26183077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8.
    Konuma T; Miyazaki Y; Uchida N; Ohashi K; Kondo T; Nakamae H; Takahashi S; Mori T; Ozawa Y; Kato C; Iwato K; Fukuda T; Ichinohe T; Atsuta Y; Ishiyama K;
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):75-80. PubMed ID: 27777139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patients with high-risk or transformed myelodysplastic syndrome proceed directly to allogeneic transplant without prior cytoreduction by remission-induction chemotherapy or hypomethylating agent therapy?
    de Witte TM; Bowen D; Robin M; Malcovati L; Mufti G; Niederwieser D; Yakoubagha I; Kröger N;
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S42-5. PubMed ID: 25486954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Study Comparing Stem Cell Transplantation Versus Conventional Therapy for Low- and Intermediate-Risk Myelodysplastic Syndromes Patients.
    Yu ZP; Ding JH; Sun AN; Ge Z; Chen BA; Wu DP
    Stem Cells Dev; 2017 Aug; 26(15):1132-1139. PubMed ID: 28494646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell Transplantation.
    Mishra A; Anasetti C
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S49-52. PubMed ID: 27521324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of induced therapy before allogeneic hematopoietic stem-cell transplantation for higher-risk myelodysplastic syndrome: experience of single centre].
    Zhou JY; He GS; Wu DP; Sun AN; Qiu HY; Jin ZM; Tang XW; Han Y; Fu ZZ; Ma X; Miao M; Xue SL; Wang Y
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3185-8. PubMed ID: 24405537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for myelodysplastic syndrome: a review.
    Parmar S; de Lima M; Deeg HJ; Champlin R
    Semin Oncol; 2011 Oct; 38(5):693-704. PubMed ID: 21943676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical analysis of allogeneic hematopoietic stem cell transplantation from human leukocyte antigen-identical siblings in 95 patients with myelodysplastic syndrome].
    Zhao T; Huang X; Liu D; Wang J; Zhang X; Wang Y; Han W; Chen H; Chen Y; Wang F; Liu K; Xu L
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):89-93. PubMed ID: 24767157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.
    Sharma P; Shinde SS; Damlaj M; Hefazi Rorghabeh M; Hashmi SK; Litzow MR; Hogan WJ; Gangat N; Elliott MA; Al-Kali A; Tefferi A; Patnaik MM
    Leuk Lymphoma; 2017 Apr; 58(4):872-881. PubMed ID: 27687869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromes.
    Christopeit M; Badbaran A; Alawi M; Zabelina T; Zeck G; Wolschke C; Ayuk F; Kröger N
    Eur J Haematol; 2016 Sep; 97(3):288-96. PubMed ID: 26680262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
    Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation for acute leukemia, chronic leukemia, and myelodysplasia.
    Popplewell L; Forman SJ
    Hematol Oncol Clin North Am; 1999 Oct; 13(5):987-1015, vi-vii. PubMed ID: 10553258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.